Sign Up / Log In
Account
Online Pharmacy
Doctor Services
Health Centre
Bulk Purchase
Corporate
Fluticasone propionate inhaler is commonly used in the treatment of asthma and chronic obstructive pulmonary disease (copd)
Fluticasone Propionate Inhaler is an anti-inflammatory, antipruritic, and vasoconstrictive. It inhibits the late phase of allergic reactions which include decreasing the density of mast cells, decreasing chemotaxis and activation of eosinophils, reducing the production of cytokine and inhibiting arachidonic acid metabolism.
Weight gain, Cushingoid features, Hyperglycemia, Hypertension, Cataract, Osteoporosis, Glaucoma, Pruritis, Skin thinning, Telangiectasia
It could be safe to consume alcohol with Fluticasone Propionate Inhaler, but it is recommended to limit the amount as the interactions are still unknown.
Animal studies have demonstrated that it can cause developmental abnormalities to the fetus and there are inadequate human studies, however, the potential benefits may allow the usage of Fluticasone Propionate Inhaler in pregnant women despite the risks. It is also recommended to only use minimum quantity for a minimum duration of the treatment.
It is unknown whether Fluticasone Propionate Inhaler or its metabolites is excreted in human breast milk. Animal studies reported that there was evidence of Fluticasone Propionate Inhaler in the rat's milk following subcutaneous administration. It is recommended to avoid using Fluticasone Propionate Inhaler during breastfeeding unless the benefits to the mother outweigh the benefits of breastfeeding to the child.
Fluticasone Propionate Inhaler usually does not affect the ability to drive. Do not drive unless you are feeling well.
In patients with renal impairment, the metabolism and elimination of this drug might be delayed in systemic absorption and thus, increases the risk of systemic toxicity. Therefore, to achieve clinical benefit, only the minimum quantity should be used for the shortest duration of treatment.
In patients with liver impairment, the metabolism and elimination of Fluticasone Propionate Inhaler might be delayed in systemic absorption and thus, increases the risk of systemic toxicity. Therefore, to achieve clinical benefit, only the minimum quantity should be used for the shortest duration of treatment.